Company Overview - Tongrentang Healthcare Investment Co., Ltd. (referred to as Tongrentang Healthcare) has submitted its listing application to the Hong Kong Stock Exchange, with CICC as its sponsor, marking the company's fourth attempt to list [1] - The company is a subsidiary of Tongrentang, focusing strategically on Chinese traditional medicine healthcare services, providing comprehensive services to individual clients and standardized management services to institutional clients [3] - As of the latest practicable date, Tongrentang Healthcare has established a tiered network of Chinese medicine healthcare services, including 12 owned offline medical institutions and one internet hospital [3][4] Market Position - In 2024, Tongrentang Healthcare holds a 0.2% market share in the non-public Chinese medicine hospital sector, ranking second in the industry, which accounts for 46.5% of the total market size of the Chinese medicine healthcare industry [1] - The company is the largest group in the non-public Chinese medicine hospital sector, with a market share of 1.7% based on total outpatient and inpatient visits in 2024 [3] Financial Performance - The company reported revenues of approximately RMB 911 million, RMB 1.153 billion, RMB 1.175 billion, and RMB 858 million for the fiscal years 2022, 2023, 2024, and the nine months ending September 30, 2025, respectively [5] - Gross profits for the same periods were approximately RMB 143 million, RMB 218 million, RMB 223 million, and RMB 156 million, with corresponding gross profit margins of 15.7%, 18.9%, 18.9%, and 18.2% [6] - The company recorded net profits of approximately -RMB 9.233 million, RMB 42.634 million, RMB 46.197 million, and RMB 23.997 million for the fiscal years 2022, 2023, 2024, and the nine months ending September 30, 2025, respectively [8] Industry Overview - The healthcare service industry in China is experiencing robust growth, with the market size expected to increase from RMB 4.644 trillion in 2019 to RMB 7.016 trillion by 2024, reflecting a compound annual growth rate (CAGR) of 8.6% [10][19] - The Chinese traditional medicine service sector is a significant part of the healthcare industry, with a market size projected to grow from RMB 659.9 billion in 2019 to RMB 1 trillion by 2024, representing a CAGR of 8.7% [19] - The number of Chinese medicine hospitals has increased from 5,232 in 2019 to 6,497 in 2024, with a CAGR of 4.4%, indicating a growing demand for traditional medicine services [14] Management Services - The management services sector for healthcare institutions in China is developing, with the market size expected to grow from RMB 8.9 billion in 2019 to RMB 29.6 billion by 2024, with a projected CAGR of 18.1% from 2025 to 2029 [22]